|本期目录/Table of Contents|

[1]李丙军,丁江华,洪建明.卡培他滨节拍化疗治疗转移性结直肠癌22例[J].医学研究与战创伤救治(原医学研究生学报),2010,12(03):247-248.
点击复制

卡培他滨节拍化疗治疗转移性结直肠癌22例()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第12卷
期数:
2010年03期
页码:
247-248
栏目:
出版日期:
2010-05-20

文章信息/Info

Title:
-
文章编号:
1672-271X(2010)03-0247-02
作者:
李丙军丁江华洪建明
332000 江西九江,南京军区庐山疗养院内三科
Author(s):
-
关键词:
结直肠癌节拍化疗卡培他滨 转移
Keywords:
-
分类号:
R735.35;R735.37
DOI:
-
文献标志码:
B
摘要:
目的 分析卡培他滨节拍化疗治疗转移性结直肠癌的临床疗效。方法 对转移性结直肠癌22例给予口服卡培他滨500 mg,2次/d,每4周为1个周期,疗程2~4个周期。结果 疾病控制率达到63.6%(14/22)。结论 卡培他滨节拍化疗治疗转移性结直肠癌具有疗效好、副作用小及患者依从性好等优点。
Abstract:
-

参考文献/References:

[1] Steinbild S, Arends J, Medinger M, et al. Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients—results of a phase II study[J]. Onkologie, 2007,30(12): 629-635.
[2] 张小田. 进展期结直肠癌的内科进展[J]. 癌症进展,2007,5(1):35-39.
[3] Lee JJ, Kim TM, Yu SJ, et al. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy[J]. Jap J Clin Oncol,2004,34(7):400-404.
[4] Yen-Revollo,JL,Goldberg RM,McLeod HL. Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines? [J]. Clin Cancer Res, 2008,14(1): 8-13.
[5] 肖文华. 恶性肿瘤的节拍化疗[J]. 临床肿瘤学杂志,2008,13(12):1139-1142.
[6] Loven D, Be'ery E, Yerushalmi R, et al. Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients[J]. Acta Oncol, 2008,47(1):104-109.

相似文献/References:

[1]王莉娜,高 静.西妥昔单抗致甲沟炎的护理体会[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):354.
[2]陈昌浩,孙岳军,王建东.受体酪氨酸激酶EphB6蛋白在结直肠癌中表达及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2016,18(04):346.[doi:10.3969/j.issn.1672-271X.2016.04.003]
 CHEN Chang-hao,SUN Yue-jun,WANG Jian-dong..Clinical significance of decreased expression of EphB6 receptor tyrosine kinase in colorectal carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(03):346.[doi:10.3969/j.issn.1672-271X.2016.04.003]
[3]陈昕涛,高倩闽,李明明综述,等.个体化用药方案在结直肠癌患者化疗中的临床应用进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):65.[doi:10.3969/j.issn.1672-271X.2020.01.015]
 CHENXin-tao,GAO Qian-min,LI Ming-ming reviewing,et al.Progress in clinical application of individualized drugs in the treatment of colorectal cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(03):65.[doi:10.3969/j.issn.1672-271X.2020.01.015]
[4]陈昕涛综述,姚厚山审校.结直肠癌腹腔镜手术治疗的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(3):283.[doi:10.3969/j.issn.1672-271X.2020.03.013]
 CHEN Xin-tao reviewing,YAO Hou-shan checking.Progress of laparoscopic surgery for colorectal cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(03):283.[doi:10.3969/j.issn.1672-271X.2020.03.013]
[5]张嘉琦,贾佩琦,苏东明.染色盒同源物3对人结直肠癌细胞增殖的影响及其机制研究[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):6.[doi:10.3969/j.issn.1672-271X.2021.01.001]
 ZHANG Jia-qi,JIA Pei-qi,SU Dong-ming.The effect of CBX3 on the biological behavior of human colorectal cancer cells and its mechanism[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(03):6.[doi:10.3969/j.issn.1672-271X.2021.01.001]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2010-05-20